Introspective Market Research (IMR) today unveiled a critical new report detailing the accelerated evolution of the Global Osteoarthritis (OA) Drugs Market . The market, valued at USD 4.70 Billion in 2023 , is forecast to more than double, reaching USD 10.38 Billion by 2032 , demonstrating a high-velocity Compound Annual Growth Rate (CAGR) of 9.2% during the 2024–2032 forecast period....